The 1980s saw the introduction of the autoinjector, which was originally—and is still most famously—used to deliver epinephrine to a person suffering from anaphylaxis. However, as time went on and drugs continued to be developed, more uses for autoinjectors were found. Dose accuracy, an efficient diffusing of medication, especially in life-threatening situations, and a proven decrease in needle-related injuries helped drive interest in applying this style of packaging to other medicines. Having a safe self-administrating option for certain medicines will also help change the landscape of health care visits, for people will be able to easily give themselves these shots with minimal concerns. This has been especially important with the spread of COVID-19 around the world, which has changed people’s mobility and required adaptation of many everyday processes and behaviors solely into the house.
This rise of autoinjectors in the pharmaceutical industry is contributing to the growth of the autoinjector market within the pharmaceutical packaging industry. In 2020, the market was valued at approximately $46 billion, with projections expecting it to be worth almost $105 billion by 2025. This rise is driven by many different factors. The prevalence of targeted therapies, which is regularly used in cancer therapies to target specific genes and proteins that factor into cancer growth. There are also concerns over the rise in food allergies in general. Scientists and medical professionals are in agreement that the number of people suffering from food allergies are on the rise, but despite research and theories, they are struggling to find the exact reason why.
Along with these medical reasons behind the increasing need for autoinjectors, an increase in regulatory approvals is occurring. This means that pharmaceutical companies are finding more applications for this style of drug administration. Currently, over 20 autoinjector drugs are on the market, and more are in development, which naturally means that there will be an increase in this type of packaging. However, there has been news in recent years of rising prices in these kinds of medicines, most famously with Mylan increasing the price of its Epi-Pen product. Companies are working to counter this issue, and more generic versions of autoinjectors are making their way onto the market. With this expansion and exploration into this innovation because of its convenience and accuracy, it should be expected that autoinjectors will be even more common than they already are in the coming years.
The autoinjector market is a rapidly-growing and important part of the pharmaceutical industry. Make sure you check out our inventory of syringe filling equipment to make sure you have what you need to keep up with the industry. You can also contact us today if there is something specific you are looking to purchase or if you have surplus equipment you would like to sell.
Previous Entries in Our Pharmaceutical Packaging Series
Part One: The State of the Global Pharmaceutical Packaging Market
Part Two: The Benefits of Blister Packaging
Tags: autoinjector drug packaging pharma pharmaceutical packaging,